BSR Insight | New Partnerships to Focus on Bringing Low-Cost Drugs to Africa
About the Author(s)
Mark Little, Director, Healthcare, Advisory Services
Publication Date
May 31, 2011
Share
With more Chinese life sciences companies expanding their research and development capabilities, these firms have an opportunity to supply much-needed medicines at a reduced rate for people in the Global South. To date, Chinese companies have focused mainly on domestic markets because of government incentives.
Given this opportunity, BSR is working with potential partners and the Chinese government to shift incentives, ramp up product-safety regulations, reduce barriers to entering new markets, and catalyze Chinese-led innovation related to health issues that prevail in both China and the Global South, including HIV, tuberculosis, and hepatitis.
Africa presents a notable opportunity because many Chinese companies (primarily in the extractives industry) have already developed relationships in the country. An initiative that focuses on health needs in Africa could also help change the mindsets of some stakeholders who have criticized Chinese companies’ and the government’s approach as representing a new wave of colonialism.
For more information on this topic and opportunities to join BSR in this effort, contact Mark Little.
About the Author(s)
Mark Little, Director, Healthcare, Advisory Services
Mark leads BSR's global healthcare practice, helping pharmaceutical, biotech, and medical device companies implement robust sustainability practices... Read more →
Share Your Thoughts
Please note, all comments are subject to moderation.